A new epigenetic signature predicts the response to immunotherapy in lung cancer
An article published in The Lancet Respiratory Medicine by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, proves that a specific pattern of epigenetic alterations in lung cancer predictss whether the tumor will […]
A new epigenetic signature predicts the response to immunotherapy in lung cancer Read More »
